HU0201722D0 - - Google Patents
Info
- Publication number
- HU0201722D0 HU0201722D0 HU0201722A HUP0201722A HU0201722D0 HU 0201722 D0 HU0201722 D0 HU 0201722D0 HU 0201722 A HU0201722 A HU 0201722A HU P0201722 A HUP0201722 A HU P0201722A HU 0201722 D0 HU0201722 D0 HU 0201722D0
- Authority
- HU
- Hungary
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29308801P | 2001-05-23 | 2001-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU0201722D0 true HU0201722D0 (instruction) | 2002-07-29 |
| HUP0201722A2 HUP0201722A2 (hu) | 2003-07-28 |
Family
ID=23127615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201722A HUP0201722A2 (hu) | 2001-05-23 | 2002-05-22 | Gyógyászati készítmények alkoholizmus és alkoholfüggőség kezelésére |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20030130322A1 (instruction) |
| EP (1) | EP1262196A3 (instruction) |
| JP (1) | JP2002370975A (instruction) |
| KR (1) | KR20020090153A (instruction) |
| CN (1) | CN1386503A (instruction) |
| AU (1) | AU4068602A (instruction) |
| CA (1) | CA2386740A1 (instruction) |
| HU (1) | HUP0201722A2 (instruction) |
| NZ (1) | NZ519032A (instruction) |
| PL (1) | PL354110A1 (instruction) |
| ZA (1) | ZA200204019B (instruction) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004233846B2 (en) * | 2003-04-29 | 2010-07-01 | Nalpropion Pharmaceuticals Llc | Compositions for affecting weight loss |
| US8758443B2 (en) | 2005-05-06 | 2014-06-24 | Titan Spine, Llc | Implants with integration surfaces having regular repeating surface patterns |
| ES2761812T3 (es) | 2005-11-22 | 2020-05-21 | Nalpropion Pharmaceuticals Inc | Composición y métodos de aumento de la sensibilidad a la insulina |
| WO2007089318A2 (en) * | 2005-11-23 | 2007-08-09 | Orexigen Therapeutics, Inc. | Compositions and methods for reducing food cravings |
| WO2007064586A1 (en) * | 2005-11-28 | 2007-06-07 | Orexigen Therapeutics, Inc. | Methods of treating anxiety disorders |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| ATE460925T1 (de) | 2006-11-09 | 2010-04-15 | Orexigen Therapeutics Inc | Mehrschichtige pharmazeutische formulierungen mit einer schnell auflösenden zwischenschicht |
| KR20160072276A (ko) | 2006-11-09 | 2016-06-22 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
| AU2007333656A1 (en) * | 2006-12-19 | 2008-06-26 | University Of Virginia Patent Foundation | Combined effects of topiramate and ondansetron on alcohol consumption |
| DK2255184T3 (da) | 2008-02-28 | 2013-07-22 | Univ Virginia Patent Found | Serotonintransportergen og behandling af alkoholisme |
| WO2009158114A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| KR101841442B1 (ko) | 2010-01-11 | 2018-03-23 | 오렉시젠 세러퓨틱스 인크. | 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법 |
| EP2588630A4 (en) | 2010-07-02 | 2013-12-25 | Univ Virginia Patent Found | MOLECULAR GENETIC APPROACH FOR THE TREATMENT AND DIAGNOSIS OF ALCOHOL AND MEDICINE DEPENDENCE |
| EP3045173A3 (en) | 2011-09-09 | 2016-09-14 | The University of Virginia Patent Foundation | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence |
| CN104470512A (zh) | 2012-06-06 | 2015-03-25 | 奥雷西根治疗公司 | 治疗超重和肥胖症的方法 |
| CN114588467B (zh) * | 2022-04-01 | 2022-11-29 | 广州蓝仕威克医疗科技有限公司 | 一种基于气体混合比例供气解决酒精中毒的方法及呼吸机 |
| CN115671107B (zh) * | 2022-12-29 | 2023-04-04 | 文韬创新药物研究（北京）有限责任公司 | 用于解酒的复方药物组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA923283B (en) * | 1991-05-29 | 1993-01-27 | Akzo Nv | Phenoxyphenyl derivatives |
| AU3419995A (en) * | 1994-09-19 | 1996-04-09 | Du Pont Merck Pharmaceutical Company, The | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| US5948807A (en) * | 1997-09-03 | 1999-09-07 | Regents Of The University Of Minnesota | Spiroindanamines and Spiroindanimides |
| EP0945133A1 (en) * | 1998-03-26 | 1999-09-29 | Lipha | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| YU56301A (sh) * | 1999-02-23 | 2004-05-12 | Pfizer Products Inc. | Inhibitori resorpcije monoamina za tretiranje poremećaja cns |
| US6071918A (en) * | 1999-07-21 | 2000-06-06 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| CN1203047C (zh) * | 1999-10-13 | 2005-05-25 | 辉瑞产品公司 | 用作一元胺重摄取抑制剂的联芳醚衍生物 |
-
2002
- 2002-05-02 EP EP02253105A patent/EP1262196A3/en not_active Withdrawn
- 2002-05-08 JP JP2002132804A patent/JP2002370975A/ja not_active Withdrawn
- 2002-05-16 AU AU40686/02A patent/AU4068602A/en not_active Abandoned
- 2002-05-17 NZ NZ519032A patent/NZ519032A/en unknown
- 2002-05-17 CA CA002386740A patent/CA2386740A1/en not_active Abandoned
- 2002-05-21 ZA ZA200204019A patent/ZA200204019B/xx unknown
- 2002-05-22 HU HU0201722A patent/HUP0201722A2/hu unknown
- 2002-05-22 US US10/153,379 patent/US20030130322A1/en not_active Abandoned
- 2002-05-23 KR KR1020020028682A patent/KR20020090153A/ko not_active Ceased
- 2002-05-23 PL PL02354110A patent/PL354110A1/xx not_active Application Discontinuation
- 2002-05-23 CN CN02120350A patent/CN1386503A/zh active Pending
-
2004
- 2004-02-20 US US10/783,196 patent/US20040162316A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1386503A (zh) | 2002-12-25 |
| US20040162316A1 (en) | 2004-08-19 |
| HUP0201722A2 (hu) | 2003-07-28 |
| EP1262196A2 (en) | 2002-12-04 |
| CA2386740A1 (en) | 2002-11-23 |
| JP2002370975A (ja) | 2002-12-24 |
| EP1262196A3 (en) | 2002-12-18 |
| ZA200204019B (en) | 2003-11-21 |
| PL354110A1 (en) | 2002-12-02 |
| AU4068602A (en) | 2002-12-05 |
| KR20020090153A (ko) | 2002-11-30 |
| NZ519032A (en) | 2003-10-31 |
| US20030130322A1 (en) | 2003-07-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |